Lantern Pharma
LTRN
LTRN
33 hedge funds and large institutions have $6.91M invested in Lantern Pharma in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.67% less ownership
Funds ownership: 21.06% → 20.39% (-0.67%)
30% less capital invested
Capital invested by funds: $9.89M → $6.91M (-$2.98M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Holders
33
Holding in Top 10
1
Calls
$82K
Puts
$10K
Top Buyers
| 1 | +$122K | |
| 2 | +$59.5K | |
| 3 | +$57.4K | |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$45.5K |
| 5 |
Renaissance Technologies
New York
|
+$38.3K |
Top Sellers
| 1 | -$83.9K | |
| 2 | -$79K | |
| 3 | -$69.8K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$38.2K |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$34.3K |
